TrialThe Lancet. Neurology2014

Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.

Phillip A Low et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.